Recombinant Human FPR3 Protein，GST

FPR3, or formyl peptide receptor 3, is a member of the G-protein coupled receptor (GPCR) family, which plays a crucial role in immune responses and inflammation. Its primary function involves mediating the chemotaxis of immune cells, particularly neutrophils, towards sites of infection or injury through the recognition of formylated peptides produced by bacteria or damaged tissues. Research has increasingly highlighted FPR3's potential in modulating inflammatory responses and its involvement in various pathological conditions, including autoimmune diseases and cancer. The ability to manipulate FPR3 signaling pathways opens avenues for therapeutic interventions aimed at enhancing immune responses or controlling excessive inflammation. Moreover, recent studies have indicated that FPR3 may interact with other receptor systems, suggesting a more complex role in immune regulation than previously understood. The production and characterization of recombinant FPR3 proteins have become essential for elucidating its structure-function relationship and developing potent ligands. This research not only provides insights into FPR3's biological significance but also presents opportunities for the design of novel therapeutic agents targeting this receptor to improve clinical outcomes in various diseases. Understanding the molecular mechanisms governing FPR3 activity could enhance our capability to harness its functions for better health management.